Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 27, 2019 FORM 4 SUBMISSION
4 Jun 27, 2019 FORM 4 SUBMISSION
4 Jun 27, 2019 FORM 4 SUBMISSION
4 Jun 27, 2019 FORM 4 SUBMISSION
4 Jun 27, 2019 FORM 4 SUBMISSION
8-K Jun 13, 2019 8-K
8-K May 30, 2019 8-K
10-Q May 9, 2019 10-Q
8-K May 9, 2019 8-K
DEF 14A Apr 26, 2019 DEF 14A
4 Apr 4, 2019 FORM 4 SUBMISSION
8-K Apr 4, 2019 8-K
SC 13G Mar 25, 2019
S-8 Mar 14, 2019 S-8
10-K Mar 14, 2019 10-K
3 Mar 11, 2019 FORM 3 SUBMISSION
8-K Mar 11, 2019 8-K
8-K Feb 15, 2019 8-K
SC 13G/A Feb 14, 2019
SC 13G/A Feb 13, 2019
SC 13G/A Feb 8, 2019 SC 13G/A
SC 13G Feb 8, 2019
4 Jan 28, 2019 FORM 4 SUBMISSION
4 Jan 28, 2019 FORM 4 SUBMISSION
4 Jan 28, 2019 FORM 4 SUBMISSION
← Newer Page 16 of 28 · 696 filings Older →